EuroEyes International Eye ClinicHKSE:01846 84 EBITDA Margin % is 14.64% as of Dec. 2025, which is 58% below its 10-year median of 35.14. GuruFocus rates HKSE:01846 with a GF Score™ of 84/100 and a GF Value™ of HK$5.52 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 664 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks better than 66.57% on this metric.
EuroEyes International Eye Clinic (HKSE:01846) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
EuroEyes International Eye Clinic EBITDA Margin % Related Terms
EuroEyes International Eye Clinic EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic EBITDA Margin % Chart
HKSE:01846 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic (HKSE:01846) has a EBITDA Margin % of 14.64% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EuroEyes International Eye Clinic and its competitors. This is 58% below median its historical median of 35.14. Over the past decade, EuroEyes International Eye Clinic's EBITDA Margin % has ranged from 16.81 to 51.82. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #222 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 33.4%.
Is EuroEyes International Eye Clinic's EBITDA Margin % too high?
EuroEyes International Eye Clinic's current EBITDA Margin % of 14.64% is 58% below median its 10-year median of 35.14. Over the past 10 years, this metric has ranged from a low of 16.81 to a high of 51.82. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. EuroEyes International Eye Clinic's value of 14.64% is 43.4% above this industry median. Based on the distribution chart, EuroEyes International Eye Clinic ranks #222 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EuroEyes International Eye Clinic has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #222 out of 664 companies for EBITDA Margin %. This puts EuroEyes International Eye Clinic in the upper half of its industry. The industry median EBITDA Margin % is 10.21. EuroEyes International Eye Clinic's value of 14.64% is 43.4% above this benchmark. Historically, EuroEyes International Eye Clinic's own EBITDA Margin % has ranged from 16.81 to 51.82 over the past decade. While the company's 10-year median is 35.14 vs. the industry median of 10.21, EuroEyes International Eye Clinic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EuroEyes International Eye Clinic's current EBITDA Margin % of 14.64% is 43.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current EBITDA Margin % is 14.64%, which is 58% below median its own 10-year median of 35.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.52, compared to a current price of HK$2.40 — trading 56.5% below its estimated fair value. The current EBITDA Margin % is 14.64%, which is 58% below median its 10-year median of 35.14 and 43.4% above the Healthcare Providers & Services industry median of 10.21. EuroEyes International Eye Clinic's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current EBITDA Margin % is 14.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.40 is trading 56.5% below its estimated GF Value™ of HK$5.52.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
EBITDA Margin %: 14.64% (58% below median its 10-year median of 35.14)
GF Value™: HK$5.52 vs. price of HK$2.40 (56.5% below fair value)
Industry Position: 43.4% above the Healthcare Providers & Services median (#222 of 664)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Business Description
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
84GF Score
Get the complete analysis for HKSE:01846
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
